Singlamedicos Pharma Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 Hyderabad, Telangana, India Amalgamated
Last Updated:
Access Report
About Singlamedicos Pharma Private Limited

Singlamedicos Pharma Private Limited, a amalgamated private limited company, was established on 15 July 2019 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909TG2019PTC168657. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

Employing 42 professional, Its leadership includes Arvind Kumar Venkat (Nominee Director), Viejay Kumar Singla (Director). Past directors included Gian Chand Singla. It holds no open charges and ₹16.35 Cr settled loans. Its latest AGM occurred on 10 August 2023, with the balance sheet filed on 31 March 2023. It is based at D.No, 7-2-1740, K.Subbaiah Pillai Godowns Main Road, Sanath Nagar, Hyderabad, Telangana, 500018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909TG2019PTC168657

  • Registration Number

    168657

  • Incorporation Date

    15 July 2019

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 6 Year, 7 Months
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 16.35 Cr
  • Revenue Growth **** 82.72%
  • Profit Growth **** -3.10%
  • Ebitda **** -15.94%
  • Net Worth -38.61%
  • Total Assets **** 34.56%
Company report

Singlamedicos Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Singlamedicos Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Singlamedicos Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Arvind Kumar Venkat Nominee Director 01 Oct 2020 Current
Viejay Kumar Singla Director 15 Jul 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Jun 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Singlamedicos Pharma.

Singlamedicos Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 82.72% increase. The company also saw a slight decrease in profitability, with a 3.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.61%.

Singlamedicos Pharma revenue growth over time
Singlamedicos Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 82.72%
*******
*******
*******
*******
Revenue from Operations
*******
 82.71%
*******
*******
*******
*******
Total Assets
*******
 34.56%
*******
*******
*******
*******
Profit or Loss
*******
 -3.10%
*******
*******
*******
*******
Net Worth
*******
 -38.61%
*******
*******
*******
*******
EBITDA
*******
 -15.94%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Singlamedicos Pharma?

In 2022, Singlamedicos Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹163,500,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 16.35 Cr
Latest Charge Details
Date Lender Amount Status
13 Jun 2022 Hdfc Bank Limited ₹3.50 M Satisfied
20 Aug 2020 Hdfc Bank Limited ₹16.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Singlamedicos Pharma?

Singlamedicos Pharma has a workforce of 42 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Singlamedicos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Singlamedicos Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Singlamedicos Pharma
Recent Activity within the Organization
  • Charges

    A charge registered on 13 Jun 2022 via Charge ID 100597439 with Hdfc Bank Limited was fully satisfied on 13 Feb 2024. was recorded as a recent event.

  • Annual General Meeting

    Progress on Singlamedicos Pharma Private Limited last Annual general meeting of members was held on 10 Aug 2023 as per latest MCA records. was documented.

  • Charges

    A charge registered on 20 Aug 2020 via Charge ID 100361366 with Hdfc Bank Limited was fully satisfied on 04 Aug 2023. was recorded as a recent event.

  • Balance Sheet

    The activity Singlamedicos Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.35 Cr with Charge ID 100597439 was registered on 13 Jun 2022. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 16.00 Cr registered on 20 Aug 2020 with Charge ID 100361366 was modified on 11 May 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Singlamedicos Pharma Private Limited?

The CIN of Singlamedicos Pharma Private Limited is U51909TG2019PTC168657.

Where is Singlamedicos Pharma Private Limited headquartered?

Singlamedicos Pharma Private Limited is headquartered at D.No, 7-2-1740, K.Subbaiah Pillai Godowns Main Road, Sanath Nagar, Hyderabad, Telangana, 500018.

When was Singlamedicos Pharma Private Limited incorporated?

Singlamedicos Pharma Private Limited was incorporated on 15 July 2019.

Who are the current directors of Singlamedicos Pharma Private Limited?

The current directors of Singlamedicos Pharma Private Limited are

What is the primary industry of Singlamedicos Pharma Private Limited?

The primary industry of Singlamedicos Pharma Private Limited is Trade.

Is Singlamedicos Pharma Private Limited a listed company?

Singlamedicos Pharma Private Limited is unlisted.

What is the capital structure of Singlamedicos Pharma Private Limited?

The authorized capital of Singlamedicos Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available